Promising results from the Neuroblastoma Phase II vaccine study at Biotec Pharmacon

Jessica Green

The ongoing vaccine study with Soluble Beta-Glucan (SBG®) from Biotec Pharmacon (”Biotec”, OSE: BIOTEC) as an oral adjuvant shows very promising treatment effects in children with relapsed high-risk neuroblastoma. The immuno-oncology investigators in New York, interpret a promising adjuvant effect of SBG® on cancer vaccine. “The results (outlined below) offer further hope for children with Neuroblastoma. Additionally, this vaccine/SBG® treatment regime has …

Springfield Nutraceuticals launches Calanus® Oil in the EU

Jessica Green

The Novel Food approval of Calanus® Oil has triggered a massive interest from European dietary supplement brand owners. Peter van Hogerhuis, CEO of Springfield Nutraceuticals in The Netherlands was the first in the European Union to see the great potential of Calanus® Oil.

Biotech North Yearly Meeting & Member Meeting Recap

Ernst Kloosterman

Approximately 32 people joined us on April 24th for BTN’s Yearly Meeting and Member Meeting at SIVA Innovasjonsenter. It began with a fresh salmon lunch and was followed by the yearly meeting in which the year’s events were covered by Chairman of the Board Børger Sørvoll and Project Manager Ernst Kloosterman. Ernst then introduced Jessica Green, the new Head of …

Økt foredling av sjømat og restråstoff i Norge – en analyse av muligheter, barrierer og lønnsomhet

Ernst Kloosterman

78 utstillere er på plass for å vise frem norske sjømatprodukter, teknologi og løsninger når verdens viktigste sjømatmesse, Seafood Expo Global og Seafood Processing Global går av stabelen i Brussel denne uka. Norge eksporterte 2,6 millioner tonn sjømat for 94,5 milliarder kroner i 2017, noe som er en verdiøkning på tre prosent. Samtidig er det rom for en vesentlig verdiskaping …